Search

everythinglearnresearchcommunity

for

Search:↓

Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

People with hair loss feel more depressed and anxious, especially women, and need help managing emotions and beliefs about their condition.

Hair loss greatly affects women's mental health and appearance satisfaction.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Over 40% of women have unwanted facial hair, which can affect their self-image, and should be managed with personalized treatment and support.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Hair loss in Telogen effluvium is often chronic, linked to stress, and lacks a confirmed treatment, but topical corticosteroids may be used.

Lichen simplex chronicus on the scalp can be diagnosed by specific hair and skin signs and treated with corticosteroids and therapy.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

Timely diagnosis and active treatment improve outcomes for massive pulmonary embolism.

Most children with rapid hair loss had a known cause, with stress and illness being top triggers, and treatments showed similar improvement.

COVID-19 may cause increased hair loss, but the exact reason is unclear and standard hair loss treatments are recommended.

Telogen effluvium is the main cause of hair loss in women in Karak, followed by androgenetic alopecia.

Hair loss affects 20% of people, more in men and those over 35, and is often associated with a sensitive scalp.

A nonchemical lotion was found effective in killing head lice and their eggs in most people, indicating it could be useful for managing head lice.

Hair loss linked to prostate enlargement; stress and family history important factors.

Finasteride and dutasteride, used for prostate issues and hair loss, can cause side effects like sexual dysfunction and mental issues, which may continue even after stopping the medication, a condition called post-finasteride syndrome, for which there's currently no cure.

Hair loss may be a delayed side effect of Multisystem Inflammatory Syndrome in children after COVID-19.

Herbal medicines can be effective alternatives for treating hair loss.

Scalp cooling might reduce hair loss from chemotherapy, but evidence is weak and other treatments are being tested.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

The review suggests seeing a dermatologist for scarring hair loss and using treatments like minoxidil or finasteride for common male and female pattern hair loss.

Substance P may contribute to hair loss by increasing oxidative stress and mitochondrial activity in hair follicles.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.